1.5.2007
News

International agreement to eliminate customs duties on approved pharmaceuticals

EU Member States adopted an international agreement to eliminate customs dutieson all new pharmaceuticals traded with the US and Switzerland. The agreement wasreached on 12 January 2007 and eliminates customs duties between the EU,Switzerland and US on finished pharmaceutical products and on the chemicalintermediates used in their production. It replaces a previous agreement from1994 that already enabled many pharmaceuticals to benefit from zero-tariffs, butdid not cover any of the more recent products. With this review, 1,290additional products have been added to the 7,329 products currently benefitingfrom duty-free treatment. The EU imports more than 80% of its pharmaceuticalsfrom the US and Switzerland, and the European Chemical Industry Council (CEFIC)believes that the agreement could save European pharmaceutical companies up to€230 million in 2007 alone.

Other articles

17.4.2026
News

Jiří Horník at Dronecon 2026

At this year’s Dronecon expert forum, KŠB partner Jiří Horník took part in two panel discussions.

At this year’s Dronecon expert forum, KŠB partner Jiří Horník took part in two panel discussions.

16.4.2026
News

Collaboration with World Bank on Analysis of Czech Business Environment

We would like to share that Kateřina Štěpánková has received a Certificate of Appreciation from World Bank in recognition of her contribution to the Subnational Business Ready in the European Union 2025 project, led by World Bank in cooperation with the European Commission (DG REGIO).

We would like to share that Kateřina Štěpánková has received a Certificate of Appreciation from World Bank in recognition of her contribution to the Subnational Business Ready in the European Union 2025 project, led by World Bank in cooperation with the European Commission (DG REGIO).

15.4.2026
News

KŠB Among Finalists for IFLR Europe Awards 2026

We are pleased to announce that Kocián Šolc Balaštík has been shortlisted for the IFLR Europe Awards 2026.

We are pleased to announce that Kocián Šolc Balaštík has been shortlisted for the IFLR Europe Awards 2026.